{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T19:48:31Z","timestamp":1769456911136,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009899","name":"Bevica Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009924","name":"Vanf\u00f8refonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jns.2012.07.036","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T09:45:30Z","timestamp":1343987130000},"page":"100-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["ATXN2 with intermediate-length CAG\/CAA repeats does not seem to be a risk factor in hereditary spastic paraplegia"],"prefix":"10.1016","volume":"321","author":[{"given":"Troels Tolstrup","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Svenstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esben","family":"Budtz-J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Eiberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lis","family":"Hasholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 6","key":"10.1016\/j.jns.2012.07.036_bb0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awp056","article-title":"Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study","volume":"132","author":"Erichsen","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2012.07.036_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrn2946","article-title":"Hereditary spastic paraplegias: membrane traffic and the motor pathway","volume":"12","author":"Blackstone","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"10.1016\/j.jns.2012.07.036_bb0015","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.46.6.1507","article-title":"Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working Group","volume":"46","author":"Fink","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2012.07.036_bb0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00401-012-0947-y","article-title":"TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1\/SPG6 mutation","volume":"124","author":"Martinez-Lage","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"5796","key":"10.1016\/j.jns.2012.07.036_bb0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"issue":"7310","key":"10.1016\/j.jns.2012.07.036_bb0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jns.2012.07.036_bb0035","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/hmg\/ddr045","article-title":"Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients","volume":"20","author":"Lee","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"16","key":"10.1016\/j.jns.2012.07.036_bb0040","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/hmg\/ddr227","article-title":"Ataxin-2 repeat-length variation and neurodegeneration","volume":"20","author":"Ross","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.jns.2012.07.036_bb0045","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/hmg\/6.11.1811","article-title":"CAG repeat expansion in autosomal dominant pure spastic paraplegia linked to chromosome 2p21-p24","volume":"6","author":"Nielsen","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.jns.2012.07.036_bb0050","doi-asserted-by":"crossref","first-page":"e17951","DOI":"10.1371\/journal.pone.0017951","article-title":"PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12003899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X12003899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:42:21Z","timestamp":1758382941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X12003899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":10,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0022510X12003899"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2012.07.036","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATXN2 with intermediate-length CAG\/CAA repeats does not seem to be a risk factor in hereditary spastic paraplegia","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2012.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}